mhurhangee/patent-ind-claim-en huggingface dataset:
A method of treating exhaust gas from an internal combustion engine , the method comprising: injecting an ammonium carbamate solution into the exhaust gas at a first location upstream of a first treatment element during a cold temperature operating state; injecting diesel exhaust fluid (DEF) into the exhaust gas at a second location between the first treatment element and a second treatment element located downstream of the first treatment element during a warm temperature operating state; converting DEF into additional ammonium carbamate solution in a reaction chamber during the warm temperature operating state; and storing the converted ammonium carbamate solution for use during the cold temperature operating state. injecting an ammonium carbamate solution into the exhaust gas at a first location upstream of a first treatment element during a cold temperature operating state; injecting diesel exhaust fluid (DEF) into the exhaust gas at a second location between the first treatment element and a second treatment element located downstream of the first treatment element during a warm temperature operating state; converting DEF into additional ammonium carbamate solution in a reaction chamber during the warm temperature operating state; and storing the converted ammonium carbamate solution for use during the cold temperature operating state.
An inkjet printer comprising: a transporting belt configured to support a medium (P) and rotate to transport the medium (P) in a transport direction (Y); a discharge unit configured to discharge a liquid onto the medium (P) supported by the transporting belt ; a support portion that supports the transporting belt; and a suction unit configured to suction the transporting belt toward the support portion , wherein provided that a direction intersecting the transport direction is a width direction (X), no through-hole is provided through the transporting belt in a thickness direction at a first end portion region being a region including an end portion on a first side of the transporting belt in the width direction (X) and a second end portion region being a region including an end portion on a second side in the width direction (X), wherein the suction unit is disposed at a position where the suction unit suctions the transporting belt at the first end portion region and the second end portion region toward the support portion ; and wherein the suction unit is disposed at a position where the suction unit does not suction the transporting belt at a center region located between the first end portion region and the second end portion region toward the support portion . a transporting belt configured to support a medium (P) and rotate to transport the medium (P) in a transport direction (Y); a discharge unit configured to discharge a liquid onto the medium (P) supported by the transporting belt ; a support portion that supports the transporting belt; and a suction unit configured to suction the transporting belt toward the support portion , wherein provided that a direction intersecting the transport direction is a width direction (X), no through-hole is provided through the transporting belt in a thickness direction at a first end portion region being a region including an end portion on a first side of the transporting belt in the width direction (X) and a second end portion region being a region including an end portion on a second side in the width direction (X), wherein the suction unit is disposed at a position where the suction unit suctions the transporting belt at the first end portion region and the second end portion region toward the support portion ; and wherein the suction unit is disposed at a position where the suction unit does not suction the transporting belt at a center region located between the first end portion region and the second end portion region toward the support portion .
A method for identifying a cancer patient as likely to positively respond to a therapy regimen, the method comprising the steps of: (a) providing samples obtained from the patient comprising at least one solid tumor sample and at least one blood plasma sample; (b) determining in the samples the sequence of at least a portion of each of the biomarkers listed in Table 1; (c) determining a measure of genetic heterogeneity in the biomarker sequence, the measure of heterogeneity selected from plasma recovery rate (PRR), mutant allele tumor heterogeneity (MATH) and multi-variant gene count (MVGC); (d) identifying the patient as likely to positively respond to a therapy regimen if the measure of genetic heterogeneity is low; or (e) identifying the patient as not likely to positively respond to a therapy regimen if the measure of genetic heterogeneity is high, wherein the cancer is selected from among non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) in stages I, II, III and IV, wherein the positive response to therapy is selected from increased progression free survival (PFS) and increased overall survival (OS), and wherein the therapy regimen is selected from treatment with FOLFOXIRI-bevacizumab and treatment FOLFOX-bevacizumab. (a) providing samples obtained from the patient comprising at least one solid tumor sample and at least one blood plasma sample; (b) determining in the samples the sequence of at least a portion of each of the biomarkers listed in Table 1; (c) determining a measure of genetic heterogeneity in the biomarker sequence, the measure of heterogeneity selected from plasma recovery rate (PRR), mutant allele tumor heterogeneity (MATH) and multi-variant gene count (MVGC); (d) identifying the patient as likely to positively respond to a therapy regimen if the measure of genetic heterogeneity is low; or (e) identifying the patient as not likely to positively respond to a therapy regimen if the measure of genetic heterogeneity is high, wherein the cancer is selected from among non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) in stages I, II, III and IV, wherein the positive response to therapy is selected from increased progression free survival (PFS) and increased overall survival (OS), and wherein the therapy regimen is selected from treatment with FOLFOXIRI-bevacizumab and treatment FOLFOX-bevacizumab.
A first electronic network node configured for a cryptographic operation using a public key matrix of the first electronic network node, the first network node comprising - a communication interface arranged for digital communication with a second network node, - a processor circuit configured to - receive as input a difficulty parameter (d), and a structure parameter ( n ), - obtain a shared matrix ( A ), the shared matrix being shared with the second network node through the communication interface, the shared matrix ( A ) being a square matrix ( k × k ) of dimension ( k ) equal to the difficulty parameter ( d ) divided by the structure parameter ( n ), the entries in the shared matrix ( A ) being integer polynomials of degree less than the structure parameter ( n ), coefficients of the polynomials preferably being selected modulo a first modulus (q), - generate a private key matrix ( S I ), entries in the private key matrix being integer polynomials of degree less than the structure parameter (n), - generate the public key matrix of the first network node ( P I ) by - computing a matrix product between the shared matrix (A) and the private key matrix ( S I ) modulo the first modulus ( q ) and modulo a reduction polynomial ( f ) with degree equal to the structure parameter (n), obtaining a matrix product, and adding noise to the entries in the matrix product, and - send the public key matrix of the first network node to the second network node. - a communication interface arranged for digital communication with a second network node, - a processor circuit configured to - receive as input a difficulty parameter (d), and a structure parameter ( n ), - obtain a shared matrix ( A ), the shared matrix being shared with the second network node through the communication interface, the shared matrix ( A ) being a square matrix ( k × k ) of dimension ( k ) equal to the difficulty parameter ( d ) divided by the structure parameter ( n ), the entries in the shared matrix ( A ) being integer polynomials of degree less than the structure parameter ( n ), coefficients of the polynomials preferably being selected modulo a first modulus (q), - generate a private key matrix ( S I ), entries in the private key matrix being integer polynomials of degree less than the structure parameter (n), - generate the public key matrix of the first network node ( P I ) by - computing a matrix product between the shared matrix (A) and the private key matrix ( S I ) modulo the first modulus ( q ) and modulo a reduction polynomial ( f ) with degree equal to the structure parameter (n), obtaining a matrix product, and adding noise to the entries in the matrix product, and - computing a matrix product between the shared matrix (A) and the private key matrix ( S I ) modulo the first modulus ( q ) and modulo a reduction polynomial ( f ) with degree equal to the structure parameter (n), obtaining a matrix product, and adding noise to the entries in the matrix product, and - send the public key matrix of the first network node to the second network node.
Method for determining levels of interactions between biomolecules, such as proteins, in a sample, comprising providing a first and a second information carrying (IC) oligonucleotide, wherein the first and second IC oligonucleotide are attached, covalently or non-covalently, to a first and a second affinity reagent, such as antibodies, that have the capacity to bind to a first and a second biomolecule, wherein the first and second IC oligonucleotide each comprises at least one single-stranded stretch that is complementary to a part of either an information receiving (IR) oligonucleotide or an activating oligonucleotide, thereby, upon hybridisation of the at least one single-stranded stretch in at least one of the first and second IC oligonucleotides to its complementary part of another oligonucleotide, enables measurement of the relative proportion of interacting and non-interacting first and second biomolecules in the sample at a single cell or single molecular level, wherein the single-stranded stretch of the first and second IC oligonucleotides enables interaction (a) between the first and/or second IC oligonucleotide and an information receiving (IR) oligonucleotide, wherein the (IR) oligonucleotide carries at least two cleavage motif sites that upon hybridization to an IC oligonucleotide become double-stranded to allow cleavage, or (b) between the first and/or second IC oligonucleotide and an activating oligonucleotide, wherein the IC oligonucleotides connected to said antibodies are designed to contain hairpin structures, and wherein said IC oligonucleotides are modified with fluorophores and quenchers, which are positioned so that only one fluorophore per oligonucleotide can emit light, wherein the hybridization between the first and/or second IC oligonucleotide and the activating oligonucleotide restructures the positions of fluorophores and quenchers, such that the one signalling fluorophore allows for discrimination between interacting and non-interacting biomolecules. (a) between the first and/or second IC oligonucleotide and an information receiving (IR) oligonucleotide, wherein the (IR) oligonucleotide carries at least two cleavage motif sites that upon hybridization to an IC oligonucleotide become double-stranded to allow cleavage, or (b) between the first and/or second IC oligonucleotide and an activating oligonucleotide, wherein the IC oligonucleotides connected to said antibodies are designed to contain hairpin structures, and wherein said IC oligonucleotides are modified with fluorophores and quenchers, which are positioned so that only one fluorophore per oligonucleotide can emit light, wherein the hybridization between the first and/or second IC oligonucleotide and the activating oligonucleotide restructures the positions of fluorophores and quenchers, such that the one signalling fluorophore allows for discrimination between interacting and non-interacting biomolecules.
A process for refining crude oil, comprising a separation unit of the crude oil, said separation unit consisting of one atmospheric distillation unit for separating the various fractions, among which fractions the heaviest fraction, also named atmospheric distillation residue which is sent to units for the conversion of the heavy fractions; units for improving the quality of some of the fractions obtained by actions on the chemical composition of their constituents, and units for the removal of undesired components; characterized in that the heaviest fraction is sent to the conversion unit which comprises at least one hydroconversion reactor in slurry phase or of the ebullated bed type, wherein hydrogen or a mixture of hydrogen and H 2 S is introduced in the presence of a nanodispersed hydrogenation catalyst or, when ebullated bed is used a supported heterogeneous hydroconversion catalyst is used in addition to the nanodispersed hydrogenation catalyst, and wherein a non-converted asphaltene liquid is separated from a gas phase leaving the hydroconversion reactor; and wherein the gas phase obtained either after or before the separation of non-converted asphaltene liquid is partially condensed to obtain products having a boiling point higher than 380°C, wherein said products, having a boiling point higher than 380°C, are sent back to said hydroconversion reactor, so that the conversion products extracted can be distilled for at least 60% by weight at 380°C.
A system for segmenting medical images, the system comprising: a database configured to store a plurality of medical images acquired by an image acquisition device, including a first medical image of an object and a second medical image of the object, wherein the object is an anatomical structure of a patient; and a processor, configured to: determine a first structure label map for the first medical image using a first classifier model trained on first training images from a population of patients; register the first medical image and the first structure label map to the second medical image to generate a registered second medical image and a second structure label map; train a second classifier model using accumulated training data comprising the registered second medical image, the second structure label map, and the first training images from the population of patients; and determine an updated second structure label map associated with the second medical image using the second classifier model. a database configured to store a plurality of medical images acquired by an image acquisition device, including a first medical image of an object and a second medical image of the object, wherein the object is an anatomical structure of a patient; and a processor, configured to: determine a first structure label map for the first medical image using a first classifier model trained on first training images from a population of patients; register the first medical image and the first structure label map to the second medical image to generate a registered second medical image and a second structure label map; train a second classifier model using accumulated training data comprising the registered second medical image, the second structure label map, and the first training images from the population of patients; and determine an updated second structure label map associated with the second medical image using the second classifier model. determine a first structure label map for the first medical image using a first classifier model trained on first training images from a population of patients; register the first medical image and the first structure label map to the second medical image to generate a registered second medical image and a second structure label map; train a second classifier model using accumulated training data comprising the registered second medical image, the second structure label map, and the first training images from the population of patients; and determine an updated second structure label map associated with the second medical image using the second classifier model.
A method for obtaining service data, comprising: sending , by a data analysis network element, a first data request to a service network element, wherein the first data request comprises a service identifier corresponding to service data; receiving , by the data analysis network element, the service data corresponding to the service identifier from the service network element, wherein the service data comprises a combination of the following: the service identifier, first data, and second data, wherein the service identifier is used to identify a service type corresponding to the service data, the first data comprises a terminal identifier, and the second data comprises a feature value list obtained through normalization processing, wherein before the sending, by the data analysis network element, the first data request to the service network element, the method comprises: receiving , by the data analysis network element, a service identifier allocation request from the service network element; obtaining, by the data analysis network element, the service identifier; and sending , by the data analysis network element, a service identifier allocation response to the service network element, wherein the service identifier allocation response comprises the service identifier. sending , by a data analysis network element, a first data request to a service network element, wherein the first data request comprises a service identifier corresponding to service data; receiving , by the data analysis network element, the service data corresponding to the service identifier from the service network element, wherein the service data comprises a combination of the following: the service identifier, first data, and second data, wherein the service identifier is used to identify a service type corresponding to the service data, the first data comprises a terminal identifier, and the second data comprises a feature value list obtained through normalization processing, wherein before the sending, by the data analysis network element, the first data request to the service network element, the method comprises: receiving , by the data analysis network element, a service identifier allocation request from the service network element; obtaining, by the data analysis network element, the service identifier; and sending , by the data analysis network element, a service identifier allocation response to the service network element, wherein the service identifier allocation response comprises the service identifier. receiving , by the data analysis network element, a service identifier allocation request from the service network element; obtaining, by the data analysis network element, the service identifier; and sending , by the data analysis network element, a service identifier allocation response to the service network element, wherein the service identifier allocation response comprises the service identifier.
A spunbonded nonwoven fabric comprising a fiber web of mixed filament yarns of a first filament composed of a recycled polyester having a melting point of 255 °C or more, and a second filament prepared from a copolyester having a melting point that is lower by 30 °C or more than that of the first filament, wherein the recycled polyester contains a recycled material of a waste polyester polymer obtained by using a monomer composition in which the ratio of diethylene glycol to ethylene glycol is 1.30 or less, and has an intrinsic viscosity (IV) of 0.60 to 0.80 dl/g, and a crystallization temperature of 175 °C or more and lower than 185 °C. a fiber web of mixed filament yarns of a first filament composed of a recycled polyester having a melting point of 255 °C or more, and a second filament prepared from a copolyester having a melting point that is lower by 30 °C or more than that of the first filament, wherein the recycled polyester contains a recycled material of a waste polyester polymer obtained by using a monomer composition in which the ratio of diethylene glycol to ethylene glycol is 1.30 or less, and has an intrinsic viscosity (IV) of 0.60 to 0.80 dl/g, and a crystallization temperature of 175 °C or more and lower than 185 °C.
Charger housing comprising - an operating side , - at least one battery charging space , which is accessible from the operating side , - a first housing outer wall region on a first housing side , said first housing side forming, in a first use position (G1) of the charger housing, a bottom side thereof, and - a second housing outer wall region on a second housing side , said second housing side being non-parallel to the first housing side and forming, in a second use position (G2) of the charger housing, a bottom side thereof, and - a water discharge structure for discharge of water out of the charger housing, wherein the water discharge structure contains at least one first water outlet opening (6a 1 ) in the first housing outer wall region and at least one second water outlet opening (7 1 ) in the second housing outer wall region , characterized in that - the first housing outer wall region extends in a concavely descending manner from an elevated first central region to at least one lower-lying first side edge region , and at least one (6a 1 ) of the one or more first water outlet openings is situated in the at least one lower-lying first side edge region and/or - the second housing outer wall region extends in a convexly descending manner from at least one elevated second side edge region to a lower-lying second central region , and at least one of the one or more second water outlet openings (7 1 ) is situated in the lower-lying second central region . - an operating side , - at least one battery charging space , which is accessible from the operating side , - a first housing outer wall region on a first housing side , said first housing side forming, in a first use position (G1) of the charger housing, a bottom side thereof, and - a second housing outer wall region on a second housing side , said second housing side being non-parallel to the first housing side and forming, in a second use position (G2) of the charger housing, a bottom side thereof, and - a water discharge structure for discharge of water out of the charger housing, wherein the water discharge structure contains at least one first water outlet opening (6a 1 ) in the first housing outer wall region and at least one second water outlet opening (7 1 ) in the second housing outer wall region , characterized in that - the first housing outer wall region extends in a concavely descending manner from an elevated first central region to at least one lower-lying first side edge region , and at least one (6a 1 ) of the one or more first water outlet openings is situated in the at least one lower-lying first side edge region and/or - the second housing outer wall region extends in a convexly descending manner from at least one elevated second side edge region to a lower-lying second central region , and at least one of the one or more second water outlet openings (7 1 ) is situated in the lower-lying second central region .